Literature DB >> 7598759

Mutant p53 protein associated with chemosensitivity in breast cancer specimens.

O Koechli, G N Schaer, B Seifert, R Hornung, U Haller, U Eppenberger, H Mueller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7598759     DOI： 10.1016/s0140-6736(94)90447-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Apoptosis: molecular mechanisms and implications for cancer chemotherapy.

Authors:  H J Guchelaar; A Vermes; I Vermes; C Haanen
Journal:  Pharm World Sci       Date:  1997-06

2.  Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells.

Authors:  H P Rutz; M Mariotta; M von Knebel Doeberitz; R O Mirimanoff
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621

Review 3.  P53, apoptosis, and breast cancer.

Authors:  D M Barnes; R S Camplejohn
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

4.  p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study.

Authors:  F Buttitta; A Marchetti; A Gadducci; S Pellegrini; M Morganti; V Carnicelli; S Cosio; O Gagetti; A R Genazzani; G Bevilacqua
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.

Authors:  J S Kovach; A Hartmann; H Blaszyk; J Cunningham; D Schaid; S S Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

6.  Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.

Authors:  E Niskanen; C Blomqvist; K Franssila; P Hietanen; V M Wasenius
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis.

Authors:  Y Maehara; M Tomoda; S Hasuda; A Kabashima; E Tokunaga; Y Kakeji; K Sugimachi
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas.

Authors:  Y Kakehi; E Ozdemir; T Habuchi; H Yamabe; T Hashimura; Y Katsura; O Yoshida
Journal:  Jpn J Cancer Res       Date:  1998-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.